Recro Pharma Inc To Discuss Acquisition Of IriSys LLC Transcript
Good day, ladies and gentlemen, and welcome to Recro's webcast today. (Operator Instructions) As a reminder, this webcast may be recorded. Please note that the slides for today's presentation are viewer controlled. Please advance them using the arrow on the right.
I would now like to hand the conference over to Stephanie Diaz of Recro's Investor Relations Group. Please go ahead.
Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer. Today, we'll be providing an overview of Recro's recent acquisition of IRISYS Inc. After our prepared remarks, we will welcome questions.
Before we begin, I'd like to caution that comments made during this webcast today, August 19, 2021, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and concerning the current beliefs of the company, which involve a number of assumptions, risks and uncertainties. Actual results could differ from these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |